Lin Elizabeth Yeu — SEC Form 4 filings
SEC reporting owner CIK 1842190. 14 Form 4 filings on record with FilingPulse; latest filed 2026-09-09.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-01-30 to 2026-09-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 12 legs across 5 filings — 29,759 shares, $2,403,606 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 5,386 shares @ $90.00 ($484,740) in Tarsus Pharmaceuticals, Inc., filed 2026-09-09.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | Chief Medical Officer | 12 | — | 12 legs · 29,759 sh · $2,403,606 | 17 |
| STAAR SURGICAL CO (STAA) | Director | 2 | — | — | 4 |
Form 4 filings — Lin Elizabeth Yeu
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-09 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 5,387 @ $85 · Sale (S): 5,386 @ $90 · Sale (S): 1,590 @ $85 · Sale (S): 1,590 @ $90 | EDGAR |
| 2026-09-03 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 4,601 @ $73.86 · Sale (S): 5,387 @ $80 · Sale (S): 1,590 @ $80 | EDGAR |
| 2026-03-19 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale (S): 375 @ $69.42 · Sale (S): 379 @ $68.71 · Sale (S): 390 @ $67 | EDGAR |
| 2026-03-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 2,511 · Option exercise (M): 2,511 (derivative) @ $0 | EDGAR |
| 2026-03-09 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 27,310 (derivative) @ $0 · Grant/award (A): 17,161 (derivative) @ $0 | EDGAR |
| 2025-12-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 6,819 · Sale (S): 2,078 @ $79.50 · Option exercise (M): 6,819 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 5,341 (derivative) @ $0 · Grant/award (A): 9,708 (derivative) @ $0 | EDGAR |
| 2025-06-17 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 3,350 · Sale (S): 1,006 @ $41.08 · Option exercise (M): 3,350 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 15,314 (derivative) @ $0 · Grant/award (A): 10,045 (derivative) @ $0 | EDGAR |
| 2024-11-06 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 41,074 (derivative) @ $0 · Grant/award (A): 27,278 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Option exercise (M): 3,350 · Option exercise (M): 3,350 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | STAAR SURGICAL CO (STAA) | Grant/award (A): 2,244 @ $0 · Grant/award (A): 4,010 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 5,000 (derivative) @ $0 · Grant/award (A): 3,350 (derivative) @ $0 | EDGAR |
| 2024-01-30 | 4 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1842190 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →